Life Stressors Could Contribute to Multiple Sclerosis Flares, Disability
Researchers discovered that stressful events in childhood and adulthood contributed significantly to participants’ level of disability and multiple sclerosis flares.
Researchers discovered that stressful events in childhood and adulthood contributed significantly to participants’ level of disability and multiple sclerosis flares.
FIND-seq combines nucleic acid cytometry, microfluidics, and droplet sorting to isolate and analyze cells of interest in multiple sclerosis.
Helius Medical Technologies Inc announces the addition of Oregon Health & Science University to its Therapeutic Experience Program.
Thalamic atrophy needs to be considered in clinical studies of the functional abilities of individuals with multiple sclerosis, per research.
Read MoreNational Multiple Sclerosis Society awards grant to Kessler Foundation’s John DeLuca, PhD, to continue multiple sclerosis curriculum.
Read MoreAccelerated Cure Project and others are collaborating to study immune response to COVID-19 vaccinations of people living with MS.
Read MoreA new analysis shows that the amount a country spends on health care may help explain the link between MS and latitude.
Read MoreThe Multiple Sclerosis Association of America launches the Ultimate MS Treatment Guide to help people with MS learn about therapies.
Read MoreHelius Medical Technologies Inc, a neurotech company, reports financial results for the quarter that ended June 30, 2022.
Read MoreA MedUni Vienna study suggests that the retina can be used as a prognostic marker to predicts the severity of future MS relapses.
Read MoreFor people with multiple sclerosis, there are specific factors that may affect a person’s physical and mental quality of life.
Read MoreMultiple sclerosis patients receiving anti-CD20 therapy saw strong T-cell activation after receiving two doses of the COVID-19 vaccine.
Read MoreMymee has acquired Berlin-based Breakthrough Health, the creator of the mobile app Emilyn for people with multiple sclerosis (MS).
Read MoreVia the FENhance study, AHN doctors are exploring the use of a new drug to treat relapsing or primary progressive multiple sclerosis.
Read MoreExperts encourage ongoing investigation of the benefits of exercise for people with multiple sclerosis, citing shortcomings of other studies.
Read MoreRune Labs is enrolling patients with multiple sclerosis in a study to identify neurophysiological biomarkers of the disease.
Read MorePoNS Therapy training for physical therapists treating patients with multiple sclerosis is now available on demand from Helius.
Read MoreVirtual reality may increase the effectiveness of cognitive rehabilitation and exercise training in individuals with MS, per Kessler.
Read More